Ed Zitron's OpenAI Takedown Lands as an IPO Warning Shot

A 17,000-Word Document That Functions as a Weapon

What makes Zitron's publication an event rather than an essay is its instrumentality. The promotional copy announced "The Hater's Guide To OpenAI" as a decade-long accounting of Sam Altman's claims against reality ^[19] — but the sentence that circulated was the conclusion: this company cannot be allowed to go public. That framing transforms a long-form critique into a shareable verdict. The AI-skeptic community on Bluesky did not engage with the piece as analysis to be debated; they passed it as evidence to be deployed.

Liability as the Load-Bearing Argument

The structural claim that gives Zitron's argument its current force is not about product quality — it is about legal exposure and its deliberate foreclosure. The concern circulating in parallel threads was precise: not that AI systems might cause harm, but that legislators were already moving to protect companies from liability for those harms before the harms occurred ^[1]. Zitron's IPO argument slots into that framework directly. If liability protection is legislated before OpenAI's public offering, the company captures a legal shield at the moment it captures public capital — a sequence that the AI-skeptic community treats as the actual con, distinct from any individual product failure.

The co-conspirator framing that spread alongside Zitron's piece extends this logic. The claim was not that Microsoft, SoftBank, and NVIDIA were deceived — it was that they are "responsible for any harm that follows" ^[18] because they amplified claims they had reason to doubt. That is a meaningful escalation in how accountability is being assigned. It moves the target from OpenAI's internal decisions to the network of institutional actors whose participation made those decisions consequential.

Ethics Policy as Contract Qualification

The most precise piece of evidence circulating this week was not from Zitron's newsletter but from a brief observation about the defense contract: the company that dropped its ethics policy lost the bid; the one that kept its ethics policy won ^[5]. That inversion collapses the usual critique of ethics washing. The complaint about performative AI ethics has typically been that ethics policies are costless gestures. The defense contract story suggests the opposite: ethics policy is now a procurement signal with real commercial value, which means labs have a financial incentive to maintain the appearance of ethical commitments regardless of what those commitments actually constrain.

This is the condition that makes Zitron's longer argument land harder than it otherwise would. The "Hater's Guide" is, among other things, a document that tries to establish that OpenAI's public commitments have repeatedly diverged from its private decisions ^[19]. In a market where ethics policy functions as a contract qualifier, a documented history of that divergence is not just a reputational liability — it is a procurement risk. The piece is circulating in part because the audience understands that.

The Anthropic Pressure from the Other Direction

Zitron's OpenAI argument landed the same week that Anthropic's Claude became its own ethics conversation, and the juxtaposition was not flattering to either company. The detail circulating about Claude's Mythos model — that an Anthropic employee described it as something that "should feel terrifying" ^[15] — was received as evidence that even the lab most associated with safety-forward positioning is shipping systems whose internal characterization does not match its public communications. One commenter read Anthropic's approach as either "responsible AI development or an expertly-executed hype maneuver" and went with the latter ^[6].

What this creates is a pincer argument that the AI-skeptic community has been building toward for months: OpenAI is accused of deliberate misrepresentation across a decade ^[19]; Anthropic is accused of safety theater dressed as caution. The implication is that the choice between labs is not a choice between different ethical orientations — it is a choice between different public relations strategies.

What Circulation Produces and What It Does Not

Zitron's piece will accomplish specific things. It will appear in the briefing documents of journalists covering the OpenAI IPO. It will supply language to the congressional staffers who are already looking for structured critiques they can deploy in hearings. The developers and researchers who circulated it most widely will cite it in public comments on regulatory proceedings. These are real effects.

What the piece will not do is halt the offering. The AI-skeptic community that engaged most intensely with the publication is skilled at documentation, distribution, and the construction of persuasive records — it is not positioned to intervene in a capital markets process. Zitron's piece becomes the most comprehensive written record of the critical case against OpenAI's public offering, which means it will be cited after the fact more than it will be acted on before it. The developers who spent this week passing it around have already written the footnotes to the retrospective.